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Here we detail proteomics data that describe the acetyl-lysine
proteome of blood platelets (Aslan et al., 2015 [1]). An afﬁnity
puriﬁcation – mass spectrometry (AP-MS) approach was used to
identify proteins modiﬁed by Nε-lysine acetylation in quiescent,
washed human platelets. The data provide insights into potential
regulatory mechanisms of platelet function mediated by protein
lysine acetylation. Additionally, as platelets are anucleate and lack
histone proteins, they offer a unique and valuable system to study
the regulation of cytosolic proteins by lysine acetylation. The mass
spectrometry proteomics data have been deposited to the Pro-
teomeXchange Consortium (Vizcaino et al., 2014 [2]) via with
PRIDE partner repository with the dataset identiﬁer PXD002332.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableubject area Biology
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acquiredData acquired on a Thermo Orbitrap Fusion Tribrid Mass Spectrometer
conﬁgured with an EasySpray NanoSourceata format .raw (raw mass spectrometry data ﬁles)
xperimental
factorsWashed human platelet lysates digested with trypsin.xperimental
featuresAcetyl-lysine peptides from platelet lysate digests were enriched using Cell
Signaling PTMScan Acetyl-Lysine Motif Kit.ata source
locationProteomics Shared Resource, Oregon Health & Science University, Medical
Research Building Room 521, 3181 SW Sam Jackson Park Road, Portland, OR
97239 USAata accessibility Deposited to the ProteomeXchange with identiﬁer PXD002332. http://pro
teomecentral.proteomexchange.org/cgi/GetDataset?ID¼PXD002332Value of the data This data provides the ﬁrst description of the platelet acetyl-lysine proteome.
 Platelets – the cellular mediators of hemostasis and thrombosis – are anucleate and lack histones,
yet they are molecularly equipped to regulate and execute adhesion, cytoskeletal remodeling,
metabolic, secretion, apoptotic and other processes common to cellular function and physiology.
Accordingly, platelets serve as an ideal cellular model to study roles of lysine acetylation in cell
biology apart from roles in transcriptional regulation.
 The data suggest roles for lysine acetylation in the regulation of actin cytoskeletal dynamics,
mitochondrial metabolic processes and other cellular activities in platelets.
 Given the developing roles of lysine acetylation in the regulation of diverse cellular activities, this
data is important for understanding the molecular basis of platelet function.
 As aspirin – a prevalent antiplatelet drug – acts as a generalized acetylation agent that is capable of
modifying lysine residues by Nε-acetylation, the data offers insights into potential secondary
targets of aspirin that may impact cellular function.1. Data, experimental design, materials and methods
1.1. Data
The data in the PRIDE Archive provide the ﬁrst description of the acetyl-lysine proteome of pla-
telets – the cellular mediators of hemostasis and thrombosis [3].1.2. Preparation of washed human platelets
Puriﬁed platelets were isolated from 100 ml human venous blood drawn from healthy volunteers
by venipuncture into sodium citrate in accordance with an IRB-approved protocol at Oregon Health &
Science University as previously described [1,4]. Brieﬂy, citrated blood was centrifuged at 200g
(20 min) to obtain platelet rich plasma (PRP). PRP was centrifuged at 1000g (10 min) in the presence
of prostacyclin (0.1 μg/ml). PRP-isolated platelets were resuspended in modiﬁed HEPES/Tyrode buffer
(129 mM NaCl, 0.34 mM Na2HPO4, 2.9 mM KCl, 12 mM NaHCO3, 20 mM HEPES, 5 mM glucose, 1 mM
MgCl2; pH 7.3) and washed one time with centrifugation at 1000g for 10 min in modiﬁed HEPES/
Tyrode buffer. Puriﬁed platelets (497.5% purity as determined by ﬂow cytometry) were collected into
in modiﬁed HEPES/Tyrode buffer for proteomics analyses described below.
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1.3.1. Sample preparation and digestion
Washed human platelets were spun at 1000g for 10 min. The resulting pellet was suspended in
5 ml of deionized 8 M urea containing 10 mM triethylammonium bicarbonate (TEAB) supplemented
with deacetylase and sirtuin inhibitors (10 mM nicotinamide and 10 μM SAHA). The platelet samples
were then lysed by probe sonication (Model 60 Sonic Dismembrator, Fisher Scientiﬁc) at a 15 W
setting for 15 s, with cooling on ice for 30 s for 3 treatments. Proteins were reduced with 18 μl of
1.25 M dithiothreitol and incubation at 55 °C for 30 min. Samples were then cooled to room tem-
perature and cysteines were alkylated with the addition of 500 μl of 100 mM idoacetamide (15 min
incubation). Sample was then diluted with 15 ml of 10 mM TEAB (þ10 mM nicotinamide and 10 μM
SAHA) and digested overnight at 37 °C with slow rotation following addition of 200 μg of MS Grade
Trypsin (Thermo Scientiﬁc) dissolved in 200 μ1 of 1 mM HCl. Following digestion, the sample was
acidiﬁed with TFA at a ﬁnal 1% concentration and centrifuged at 2000g for 15 min. Next, peptides in
the supernatant were solid phase extracted using a Sep-Pak Plus C18 cartridge (waters) and eluted in
5 ml of 40% acetonitrile, 0.1% TFA. The ﬁnal recovered peptides had a mass of 2.5 mg, as determined
by BCA assay using BSA as a standard (Thermo Scientiﬁc). The peptides were then shell frozen using a
dry ice bath and dried in a vacuum centrifuge for 20 h without heating.
1.3.2. Acetyl-lysine peptide enrichment
Acetylated peptides were puriﬁed using a PTMScan Acetyl-Lysine Motif Kit (Cell Signaling) using
80 μl of immunoafﬁnity beads following the manufacturer's recommendations. Afﬁnity puriﬁed
peptides were then solid phase extracted using a Sep-Pak light C18 cartridge and eluted in 1 ml of 40%
acetonitrile, 0.1% TFA. Following vacuum centrifugation, the peptides were dissolved in 20 μl of
10 mM ammonium formate (pH 10) and separated by 2-D chromatography using tandem reverse
phase separations at high and low pH. A Dionex NCS-3500RS UltiMate RSLCnano UPLC system was
used for sample loading and 2nd dimension reverse phase separation, and a Dionex NCP-3200RS
UltiMate RSLCnano UPLC systemwas used for dilution of the 1st dimension reverse phase eluent. The
sample was injected for 10 min onto a NanoEase 5 μm XBridge BEH130 C18 300 μm5 cm column
(Waters) at 3 μl/min in a mobile phase containing 10 mM ammonium formate (pH 10), 2% acetonitrile
(ACN). Next, peptides were eluted by sequential injection of 20 μl volumes of 20, 24, 28, and 40% ACN
in 10 mM ammonium formate (pH 10) at a 3 ul/min ﬂow rate. Eluted peptides were then diluted at a
tee with mobile phase containing 0.1% formic acid at a 12 ul/min ﬂow rate and bound to an Acclaim
PepMap 100 μm2 cm NanoViper C18, 5 μm trap column on a switching valve. Following loading,
the trap columnwas switched on-line to a PepMap RSLC C18, 2 μm, 75 μm25 cm EasySpray column
(Thermo Scientiﬁc). Peptides were then separated at low pH in the 2nd dimension using a 7.5–30%
ACN gradient over 83 min in mobile phase containing 0.1% formic acid at a 300 nl/min ﬂow rate.
1.3.3. Mass spectrometry data acquisition
Tandem mass spectrometry data was collected using a Thermo Orbitrap Fusion Tribrid Mass
Spectrometer conﬁgured with an EasySpray NanoSource (Thermo Scientiﬁc). Survey scans were
performed in the Orbitrap mass analyzer, and data-dependent MS2 scans in the linear ion trap
following HCD fragmentation in the instrument's ion routing multipole, as detailed [1]. Peptides
were identiﬁed using Protein Discoverer, version 1.4 (Thermo Scientiﬁc), using Sequest HT, a
human Swiss-Prot database downloaded in April 2013 containing 20,221 protein entries, static
modiﬁcation of þ57.021 for C residues, variable modiﬁcations of þ15.995 and þ42.011 for M
and K residues, respectively, parent ion tolerance of þ/10 ppm, fragment ion tolerance of
0.6 Da, monoisotopic masses, and trypsin cleavage (max 2 missed cleavages). Searches used a
reversed sequence decoy strategy to control peptide false discovery [5] and identiﬁcations were
validated by Percolator software [6]. Only peptides with q-values o0.01 were accepted, cor-
responding to a false discovery rate of below 1%.
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An assessment of acetyl-lysine protein functional network connectivity and associated gene
ontology (GO) biological processes was performed using STRING v9.1 [7] analysis of unique Ensemble
protein identiﬁers of all identiﬁed lysine acetylated platelet proteins at a Z0.7 conﬁdence score. To
assess candidate lysine acetyltransferases involved platelet protein acetyl-lysine modiﬁcation, all
identiﬁed acetyl-lysine peptide sequences were put into the Acetylation Set Enrichment-Based (ASEB)
prediction tool (http://bioinfo.bjmu.edu.cn/huac/predict_p/) and assigned p-values predicting mod-
iﬁcation by p300/CBP and GCN5/PCAF lysine acetyltransferases [8]. To assess the relative abundance
of platelet proteins found to contain acK modiﬁcations, all platelet proteins with identiﬁed acK sites
were assigned an abundance rank as previously determined [9].
1.3.5. Data deposition
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium
[2] via the PRIDE partner repository with the dataset identiﬁer PXD002332 accessible at http://www.
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